Fosravuconazole (BMS-379224) (Synonyms: BMS-379224; E-1224) |
| Katalog-Nr.GC33996 |
Fosravuconazol (BMS-379224) (BMS-379224), ein Prodrug von Ravuconazol, ist ein oral wirksames Breitspektrum-Antimykotikum.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 351227-64-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Fosravuconazole is a prodrug of ravuconazole, with antifungal activity.
Fosravuconazole (BMS-379224) is a prodrug of ravuconazole, with antifungal activity[1].
Fosravuconazole (BMS-379224) is rapidly conversed to ravuconazole upon iv administration to rats. Fosravuconazole shows comparable efficacy at inhibiting C. albicans infection model in mice as orally administered ravuconazole[1].
[1]. Ueda Y, et al. Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3669-72.
Average Rating: 5 (Based on Reviews and 6 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *